in vivo two-photon imaging of the mouse retina - optics infobase

Post on 11-Feb-2022

7 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

limits for mouse imaging can be inferred from the ANSI maximum permissible exposure for humans by equating the photon density at the retina. This provides a scaling factor for the MPE which is equal to the square of the ratio of the numerical apertures of human (0.24) and mouse (0.49) eyes. As a result, the light levels that were used for two-photon imaging of GFP and G-CaMP3 labeled cells were, respectively, factors of 12 and 7.5 times greater than the scaled safety limits. Despite this, low-resolution fundus imaging did not reveal any noticeable damage in the retinal tissue at the imaged locations, possibly because the assumption of equivalent molecular composition of mouse and human retinas may be invalid. Therefore, initial findings suggest that safe two-photon imaging in rodents is feasible.

With the improvements discussed here, in vivo two-photon retinal imaging in mouse will permit structural and functional imaging experiments employing spatio-temporal patterns to identify new visual system pathways. Further, it has the potential to pave the way for truly non-invasive in situ functional imaging of endogenous fluorescence [9,27,28] from all retinal cell classes in the living eye.

Acknowledgments

We acknowledge funding sources: National Institutes of Health for grants EY004367, EY021166, EY022371, BRP-EY014375, EY001319, R43-EY020715, R44-AG043645-02, 5R24EY021126-03; National Science Foundation for grant AST 976783 and Polgenix, Inc. The authors thank Ted Twietmeyer, Jennifer Strazzeri, Yusufu Sulai and Jesse Schallek for their assistance with the project and the manuscript, Meike Visel for producing the AAV viral vector, and Fumitaka Osakada for providing the rabies viral vector. The image registration software DeMotion was developed by Alfredo Dubra and Zach Harvey with funding from Research to Prevent Blindness and the National Institute of Health, Bethesda, Maryland through the grants BRP-EY014375 and 5 K23 EY016700. Alfredo Dubra and Kamran Ahmad developed the adaptive optics control software.

#185482 - $15.00 USD Received 4 Mar 2013; revised 6 May 2013; accepted 17 Jun 2013; published 9 Jul 2013(C) 2013 OSA 1 August 2013 | Vol. 4, No. 8 | DOI:10.1364/BOE.4.001285 | BIOMEDICAL OPTICS EXPRESS 1293

top related